Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.
Japanese generic pharmaceutical manufacturer Sawai Pharmaceutical will purchase the assets and plans a major expansion in the U.S. market.
Four in 10 Americans reported that their daily activities were significantly impacted by poor or insufficient sleep at least once during the past seven days.
Many health systems are embracing the disruption generated by retail clinics through partnerships, utilizing clinic operations as patient acquisition points.
According to Argentum, the agreement generally provides that Argentum may commence marketing its generic equivalent product sometime prior to the expiration of the patents covering Restasis.
Food retailers have an opportunity to further advance efforts with nutrition, pharmacy and related services, partly by forming innovative collaborations with partners.
Drug Store News recently sat down with Sandy Canally, founder and CEO of The Compliance Team, to get a sneak peek at its new accreditation module and the opportunity that represents for pharmacy.
The company is reportedly set to cover up to $1500 in expenses related to medical marijuana, making 45,000 employees eligible.
Vilazodone hydrochloride tablets, the therapeutic equivalent to the reference-listed drug product Viibryd tablets of Forest Labs, treats depression.
Daewoong Pharmaceutical’s Meroprenem is a generic of Merem, developed by AstraZeneca, as a Carbapenem-series antibiotic widely used in hospitals to treat various ailments ranging from bacterial infections to general diseases.